1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with epidermal growth factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, CH; Kao, JY; Kuo, PT; Lin, JK; Lin, TP; Liu, LC; Way, TD | 1 |
Chen, Y; Ho, CT; Hseu, YC; Kao, JY; Kuo, PT; Lin, VC; Lin, YC; Way, TD; Yang, HL | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and epidermal growth factor
Article | Year |
---|---|
Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Humans; Hydrolyzable Tannins; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Prostatic Neoplasms; RNA, Messenger; Transcription, Genetic | 2009 |
Penta-O-galloyl-β-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells.
Topics: Bone Neoplasms; Cell Line, Tumor; Epidermal Growth Factor; Eukaryotic Initiation Factor-3; Gene Expression; Humans; Hydrolyzable Tannins; Male; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; TOR Serine-Threonine Kinases; Transfection | 2014 |